A study of ceralasertib for advanced cancer (Dose escalation study)

Please note - this trial is no longer recruiting patients. We hope to add results when they are available.

Cancer type:

All cancer types
Head and neck cancers
Lung cancer
Non small cell lung cancer
Stomach cancer

Status:

Closed

Phase:

Phase 1

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Matthew Krebs

Other information

AstraZeneca
Experimental Cancer Medicine Centre (ECMC)

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

14042

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

Currently rated: 3.6 out of 5 based on 13 votes
Thank you!
We've recently made some changes to the site, tell us what you think